GB2333776B - Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means - Google Patents

Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means

Info

Publication number
GB2333776B
GB2333776B GB9827704A GB9827704A GB2333776B GB 2333776 B GB2333776 B GB 2333776B GB 9827704 A GB9827704 A GB 9827704A GB 9827704 A GB9827704 A GB 9827704A GB 2333776 B GB2333776 B GB 2333776B
Authority
GB
United Kingdom
Prior art keywords
rad1
polypeptides
assays
human
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9827704A
Other versions
GB9827704D0 (en
GB2333776A (en
Inventor
Stephen Philip Jackson
Raimundo Freire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Kudos Pharmaceuticals Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Kudos Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd, Kudos Pharmaceuticals Ltd filed Critical Cancer Research Campaign Technology Ltd
Publication of GB9827704D0 publication Critical patent/GB9827704D0/en
Publication of GB2333776A publication Critical patent/GB2333776A/en
Application granted granted Critical
Publication of GB2333776B publication Critical patent/GB2333776B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB9827704A 1997-12-16 1998-12-16 Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means Expired - Fee Related GB2333776B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726575.5A GB9726575D0 (en) 1997-12-16 1997-12-16 Nucleic acid, polypeptides, assays, therapeutic methods and means

Publications (3)

Publication Number Publication Date
GB9827704D0 GB9827704D0 (en) 1999-02-10
GB2333776A GB2333776A (en) 1999-08-04
GB2333776B true GB2333776B (en) 2000-05-24

Family

ID=10823699

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9726575.5A Ceased GB9726575D0 (en) 1997-12-16 1997-12-16 Nucleic acid, polypeptides, assays, therapeutic methods and means
GB9827704A Expired - Fee Related GB2333776B (en) 1997-12-16 1998-12-16 Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9726575.5A Ceased GB9726575D0 (en) 1997-12-16 1997-12-16 Nucleic acid, polypeptides, assays, therapeutic methods and means

Country Status (6)

Country Link
EP (1) EP1037978A1 (en)
JP (1) JP2002508180A (en)
AU (1) AU1572199A (en)
CA (1) CA2313391A1 (en)
GB (2) GB9726575D0 (en)
WO (1) WO1999031234A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049042A1 (en) * 1998-03-27 1999-09-30 Icos Corporation HUMAN Rad1 CELL CYCLE CHECKPOINT
US6387658B1 (en) * 1999-09-23 2002-05-14 Rigel Pharmaceuticals, Inc. PCNA-associated cell cycle proteins, compositions and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5723996A (en) * 1996-05-03 1997-11-26 Erasmus University Human rad

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Genes & Development (1998) 12 (16) pp.2560-2573 - R.Freire et al. *
J.Biological Chem. (1998) 273 (29) pp.18332-18339 - A.Parkeret al. *

Also Published As

Publication number Publication date
EP1037978A1 (en) 2000-09-27
GB9726575D0 (en) 1998-02-11
AU1572199A (en) 1999-07-05
CA2313391A1 (en) 1999-06-24
WO1999031234A1 (en) 1999-06-24
JP2002508180A (en) 2002-03-19
GB9827704D0 (en) 1999-02-10
GB2333776A (en) 1999-08-04

Similar Documents

Publication Publication Date Title
IL136696A0 (en) Sigirr dna and polypeptides
EP1001964A4 (en) Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
AU6458400A (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
EP1186615A4 (en) Novel protein and dna thereof
GB9815423D0 (en) Assays, therapeutic methods and means
EP1018551A4 (en) Megsin protein
IL126923A0 (en) Mammalian tolloid-like gene and protein
EP1012262A4 (en) Human frezzled-like protein
EP1038958A4 (en) HUMAN Nap1 PROTEIN
GB9701710D0 (en) Mammalian protein
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
IL136695A0 (en) V201 dna and polypeptides
IL136988A0 (en) Novel nucleic acid and polypeptide
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
GB2333776B (en) Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means
EP1044216A4 (en) DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1
GB9704162D0 (en) Assay methods and means
AU9786498A (en) Human receptor proteins; related reagents and methods
EP1012160A4 (en) Tango-72 and tango-77 nucleic acid molecules and polypeptides
EP1142999A4 (en) Novel protein and dna thereof
IL179339A0 (en) Svphi-26 nucleic acids, polypeptides and methods for producing the same
EP1007540A4 (en) Dna molecules encoding human nuclear receptor proteins
GB0120368D0 (en) Assays therapeutic methods and means
IL136693A0 (en) V196 dna and polypeptides
EP1111047A4 (en) Novel protein and dna thereof

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20021216